{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:22:18Z","timestamp":1791174138008,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gen Intern Med"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1007\/bf02598985","type":"journal-article","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T09:26:38Z","timestamp":1175592398000},"page":"721-728","source":"Crossref","is-referenced-by-count":91,"title":["Why isn\u2019t warfarin prescribed to patients with nonrheumatic atrial fibrillation?"],"prefix":"10.1007","volume":"11","author":[{"given":"Rebecca J.","family":"Beyth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghal R.","family":"Antani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Covinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Margaret","family":"Chren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Seth","family":"Landefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02598985_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","volume":"1","author":"P Petersen","year":"1989","unstructured":"Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet. 1989;1:175\u20139.","journal-title":"Lancet"},{"key":"BF02598985_CR2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","volume":"323","author":"Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators","year":"1990","unstructured":"Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505\u201311.","journal-title":"N Engl J Med"},{"key":"BF02598985_CR3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJM199003223221232","volume":"322","author":"Stroke Prevention in Atrial Fibrillation Study Group Investigators","year":"1990","unstructured":"Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med. 1990;322:863\u20138.","journal-title":"N Engl J Med"},{"key":"BF02598985_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","volume":"18","author":"SJ Connolly","year":"1991","unstructured":"Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol. 1991;18:349\u201355.","journal-title":"J Am Coll Cardiol"},{"key":"BF02598985_CR5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","volume":"327","author":"MD Ezekowitz","year":"1992","unstructured":"Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992;327:1406\u201312.","journal-title":"N Engl J Med"},{"key":"BF02598985_CR6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199211123272009","volume":"327","author":"DE Singer","year":"1992","unstructured":"Singer DE. Randomized trials of warfarin for atrial fibrillation. N Engl J Med. 1992;327:1451\u20133.","journal-title":"N Engl J Med"},{"key":"BF02598985_CR7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7326\/0003-4819-115-9-727","volume":"115","author":"GW Albers","year":"1991","unstructured":"Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med. 1991;115:727\u201336.","journal-title":"Ann Intern Med"},{"key":"BF02598985_CR8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0140-6736(93)92353-U","volume":"342","author":"A Laupacis","year":"1993","unstructured":"Laupacis A. Anticoagulants for atrial fibrillation. Lancet. 1993;342:1251\u20132.","journal-title":"Lancet"},{"key":"BF02598985_CR9","doi-asserted-by":"crossref","first-page":"426S","DOI":"10.1378\/chest.102.4_Supplement.426S","volume":"102","author":"A Laupacis","year":"1992","unstructured":"Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest. 1992;102:426S-33S.","journal-title":"Chest"},{"key":"BF02598985_CR10","doi-asserted-by":"crossref","first-page":"352S","DOI":"10.1378\/chest.108.4_Supplement.352S","volume":"108","author":"A Laupacis","year":"1995","unstructured":"Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest. 1995;108:352S-9S.","journal-title":"Chest"},{"key":"BF02598985_CR11","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jama.1995.03530230025025","volume":"274","author":"BF Gage","year":"1995","unstructured":"Gage BF, Cardinalli AB, Albers GW, Owens DK. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995;274:1839\u201345.","journal-title":"JAMA"},{"key":"BF02598985_CR12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","volume":"155","author":"WM Feinberg","year":"1995","unstructured":"Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155:469\u201373.","journal-title":"Arch Intern Med"},{"key":"BF02598985_CR13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/BF02598984","volume":"11","author":"MR Antani","year":"1996","unstructured":"Antani MR, Beyth RJ, Covinsky KE, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med. 1996;11:713\u201320.","journal-title":"J Gen Intern Med"},{"key":"BF02598985_CR14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","volume":"147","author":"PA Wolf","year":"1987","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987;147:1561\u20134.","journal-title":"Arch Intern Med"},{"key":"BF02598985_CR15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","unstructured":"Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449\u201357.","journal-title":"Arch Intern Med"},{"key":"BF02598985_CR16","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM198412063112305","volume":"311","author":"JC Bailar","year":"1984","unstructured":"Bailar JC, Louis TA, Lavori PW, Polansky M. A classification for biomedical research reports. N Engl J Med. 1984;311:1482\u20137.","journal-title":"N Engl J Med"},{"key":"BF02598985_CR17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/bmj.307.6911.1045","volume":"307","author":"PMW Bath","year":"1993","unstructured":"Bath PMW, Prasad A, Brown MM, MacGregor GA. Survey of use of anticoagulation in patients with atrial fibrillation. BMJ. 1993;307:1045.","journal-title":"BMJ"},{"key":"BF02598985_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archinte.1990.00390130089012","volume":"150","author":"HJ Chang","year":"1990","unstructured":"Chang HJ, Bell JR, Deroo DB, Kirk JW, Wasson JH, Dartmouth Primary Care COOP Project. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med. 1990;150:81\u20134.","journal-title":"Arch Intern Med"},{"key":"BF02598985_CR19","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1001\/archinte.1991.00400100038006","volume":"151","author":"M Kutner","year":"1991","unstructured":"Kutner M, Nixon G, Silverstone F. Physicians\u2019 attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med. 1991;151:1950\u20133.","journal-title":"Arch Intern Med"},{"key":"BF02598985_CR20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.1995.00430030071008","volume":"155","author":"DC McCrory","year":"1995","unstructured":"McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation. Arch Intern Med. 1995;155:277\u201381.","journal-title":"Arch Intern Med"},{"key":"BF02598985_CR21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0895-4356(91)90219-Y","volume":"44","author":"KM Flegel","year":"1991","unstructured":"Flegel KM, Hutchinson TA, Groome PA, Tousignant P. Factors relevant to preventing embolic stroke in patients with non-rheumatic atrial fibrillation. J Clin Epidemiol. 1991;44:551\u201360.","journal-title":"J Clin Epidemiol"},{"key":"BF02598985_CR22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(93)90285-W","volume":"95","author":"CS Landefeld","year":"1993","unstructured":"Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med. 1993;95:315\u201328.","journal-title":"Am J Med"},{"key":"BF02598985_CR23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archinte.1994.00420130030006","volume":"154","author":"GW Albers","year":"1994","unstructured":"Albers GW, Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med. 1994;154:1443\u20138.","journal-title":"Arch Intern Med"},{"key":"BF02598985_CR24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-116-11-901","volume":"116","author":"JH Gurwitz","year":"1992","unstructured":"Gurwitz JH, Avorn J, Ross-Degnan D. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med. 1992;116:901\u20134.","journal-title":"Ann Intern Med"},{"key":"BF02598985_CR25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(89)80689-8","volume":"87","author":"CS Landefeld","year":"1989","unstructured":"Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87:144\u201352.","journal-title":"Am J Med"},{"key":"BF02598985_CR26","first-page":"687","volume":"343","author":"Stroke Prevention in Atrial Fibrillation Study Group Investigators","year":"1994","unstructured":"Stroke Prevention in Atrial Fibrillation Study Group Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet. 1994;343:687\u201391.","journal-title":"Lancet"},{"key":"BF02598985_CR27","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7326\/0003-4819-124-11-199606010-00004","volume":"124","author":"SD Fihn","year":"1996","unstructured":"Fihn SD, Callahan CM, Martin DC, McDonnell MB, Henikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med. 1996;124:970\u20139.","journal-title":"Ann Intern Med"},{"key":"BF02598985_CR28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.185.4157.1124","volume":"185","author":"A Tversky","year":"1974","unstructured":"Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185:1124\u201331.","journal-title":"Science"},{"key":"BF02598985_CR29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-97-2-262","volume":"97","author":"SA Eraker","year":"1982","unstructured":"Eraker SA, Politser P. How decisions are reached: physician and patient. Ann Intern Med. 1982;97:262\u20138.","journal-title":"Ann Intern Med"},{"key":"BF02598985_CR30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0022-1031(91)90011-T","volume":"27","author":"M Spranca","year":"1991","unstructured":"Spranca M, Minsk E, Baron J. Omission and commission in judgment and choice. J Exp Soc Psychol. 1991;27:76\u2013105.","journal-title":"J Exp Soc Psychol"},{"key":"BF02598985_CR31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/0272989X9401400204","volume":"14","author":"DA Asch","year":"1994","unstructured":"Asch DA, Baron J, Hershey JC, et al. Omission bias and pertussis vaccination. Med Decis Making. 1994;14:118\u201323.","journal-title":"Med Decis Making"},{"key":"BF02598985_CR32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.1987.03400040114035","volume":"258","author":"T Wetle","year":"1987","unstructured":"Wetle T. Age as a risk factor for inadequate treatment. JAMA. 1987;258:516.","journal-title":"JAMA"},{"key":"BF02598985_CR33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJM199310213291714","volume":"329","author":"PJ Greco","year":"1993","unstructured":"Greco PJ, Eisenberg JM. Changing physicians\u2019 practices. N Engl J Med. 1993;329:1271\u20134.","journal-title":"N Engl J Med"},{"key":"BF02598985_CR34","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1001\/jama.1991.03460170056033","volume":"265","author":"J Lomas","year":"1991","unstructured":"Lomas J. Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J. Opinion leaders versus audit and feedback to implement practice guidelines: delivery after previous cesarean section. JAMA. 1991;265:2202\u20137.","journal-title":"JAMA"},{"key":"BF02598985_CR35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-116-10-829","volume":"116","author":"CS Landefeld","year":"1992","unstructured":"Landefeld CS, Anderson PA. Guideline-based consultation to prevent anticoagulant-related bleeding: a randomized, controlled trial in a teaching hospital. Ann Intern Med. 1992;116:829\u201337.","journal-title":"Ann Intern Med"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02598985.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02598985\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02598985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T18:24:02Z","timestamp":1558203842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02598985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["BF02598985"],"URL":"https:\/\/doi.org\/10.1007\/bf02598985","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}